Home › Chronic Lymphocytic Leukemia › District of Columbia
Chronic Lymphocytic Leukemia clinical trials in District of Columbia
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT04269902A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06973187Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT02333604From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.